11 October 2013
Siberian researchers at Tomsk Polytechnic University’ Institute of High Technology Physics have developed what they call “nanodrugs” based on organic synthesis to fight various cancers, E-News reported .
It is said to be one of the most recent Russian-developed pharmaceutical compositions with targeted action. The cost of production is fairly low, the source said.
“We ‘sew’ on the surface of nanoparticles special proteins that stick to cancer cells and destroy them. This is the methodology we also use to make diagnostics substances employed in magnetic resonance imaging (MRI). Russia uses such drugs but doesn’t manufacture them,” said Prof. Viktor Filimonov, the head of the university’s biotechnology and organic chemistry chair and the nanodrug project leader.
The Siberian scientists are closely collaborating in this effort with specialists from the Institute of Metal Physics and a sizable pharma company in the Urals. In Yekaterinburg, for example, the key components of the nanoparticles are made.
According to the source, the new drugs “have already completed all testing stages” and are reported to have received the green light from regulators.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024